Your browser doesn't support javascript.
loading
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Pereira-Salgado, Amanda; Anton, Angelyn; Franchini, Fanny; Mahar, Robert K; Kwan, Edmond M; Wong, Shirley; Shapiro, Julia; Weickhardt, Andrew; Azad, Arun A; Spain, Lavinia; Gunjur, Ashray; Torres, Javier; Parente, Phillip; Parnis, Francis; Goh, Jeffrey; Steer, Christopher; Brown, Stephen; Gibbs, Peter; Tran, Ben; IJzerman, Maarten.
Afiliação
  • Pereira-Salgado A; Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Melbourne, Australia.
  • Anton A; Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
  • Franchini F; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Mahar RK; Department of Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Kwan EM; Department of Cancer Services, Eastern Health, Melbourne, Australia.
  • Wong S; Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Melbourne, Australia.
  • Shapiro J; Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
  • Weickhardt A; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Azad AA; Centre for Cancer Research and Centre for Health Policy, Faculty of Medicine, Dentistry and Health Sciences, the University of Melbourne, Melbourne, Australia.
  • Spain L; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
  • Gunjur A; Victorian Comprehensive Cancer Centre, Melbourne, Australia.
  • Torres J; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Parente P; Department of Medical Oncology, Monash Health, Melbourne, Australia.
  • Parnis F; Western Health, Melbourne, Australia.
  • Goh J; Alfred Health, Melbourne, Australia.
  • Steer C; Olivia Newton John Cancer Wellness and Research Centre, Melbourne, Australia.
  • Brown S; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Gibbs P; Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Tran B; Department of Cancer Services, Eastern Health, Melbourne, Australia.
  • IJzerman M; Olivia Newton John Cancer Wellness and Research Centre, Melbourne, Australia.
Expert Rev Pharmacoecon Outcomes Res ; 23(2): 231-239, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36541133
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Health_economic_evaluation Limite: Humans / Male País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Health_economic_evaluation Limite: Humans / Male País/Região como assunto: Oceania Idioma: En Ano de publicação: 2023 Tipo de documento: Article